From the Department of Ophthalmology, Shaare Zedek Medical Center and the Hebrew University-Hadassah Medical School, Jerusalem, Israel (Tsessler, Cohen, Zadok, Abulafia); Department of Ophthalmology, Baylor College of Medicine, Houston, Texas (Wang, Koch).
Corresponding author: Adi Abulafia, MD, Department of Ophthalmology, Shaare Zedek Medical Center, Shmuel Bait St 12, Jerusalem, Israel 9103102. Email: [email protected].
M. Tsessler and S. Cohen contributed equally to this work.
Supported in part by Sid W. Richardson Foundation (S. Cohen), Fort Worth, Texas, and an unrestricted grant from Research to Prevent Blindness, New York, New York (L. Wang and D.D. Koch).
Disclosures: A. Abulafia: consultant for Alcon Laboratories, Inc., Haag-Streit AG, and Carl Zeiss Meditec AG. L. Wang: consultant for Carl Zeiss Meditec AG and Alcon Laboratories, Inc. D.D. Koch: consultant for Alcon Laboratories, Inc., Carl Zeiss Meditec AG, and Johnson & Johnson Vision.
This work was completed as part of academic requirements necessary for completion for medical doctor degree of the faculty of medicine, Hadasa Medical School of the Hebrew University, Jerusalem.
First author:Maria Tsessler, MDDepartment of Ophthalmology, Shaare Zedek Medical Center, Jerusalem, Israel